Different kinds of experimental calcareous substrates were exposed at Lee Stocking Island (Bahamas) and One Tree Island (Great Barrier Reef, Australia) to study which endolithic bacteria, algae and fungi contribute to bioerosion and what their bioerosion rates are. The sites at Lee Stocking Island were several leeward shallow water and several windward shallow and deep‐water positions (from the Acropora palmata reef at 2 m down to 275 m depth). At One Tree Island, the experiments were conducted in patch reefs treated with P and N to study the influence of mineral nutrients on bioerosion. The exposure periods ranged from 1 week to 2 years. The micritic carbonate substrates exposed on Lee Stocking Island contained 6 genera with 15 species of cyanobacteria, green and red algae, and different kinds of microendolithic heterotrophs. The mean values of bioerosion rates measured between 1 to 2 g/m 2 /y at 275 m and 520 g/m 2 /y at one of the leeward sites. The composition of the endolithic community and the bioerosion rates changed over time. At One Tree Island, shell pieces of Tridacna were used as substrate exposed for 5 months to endolith activity. Five genera and 6 species of cyanobacteria, green and red algae and different kinds of heterotrophic microendoliths were found with bioerosion rates of 20–30 g/m 2 /y. There are differences in abundance of taxa between Lee Stocking Island and One Tree Island. The introduction of nutrients had no apparent impact on the microborer community. Controlling factors for the distribution and abundance of microborers are mainly light, but also the kind of substrate and, possibly, the biogeographic position. The results support the paleoecological importance of microendoliths.

No abstract

No abstract

Background: The German multicenter randomized phase II larynx organ preservation (LOP) trial DeLOS-II was carried out to prove the hypothesis that cetuximab (E) added to induction chemotherapy (IC) and radiotherapy improves laryngectomy-free survival (LFS; survival with preserved larynx) in locally advanced laryngeal/hypopharyngeal cancer (LHSCC).Patients and methods: Treatment-naïve patients with stage III/IV LHSCC amenable to total laryngectomy (TL) were randomized to three cycles IC with TPF [docetaxel (T) and cisplatin (P) 75 mg/m 2 /day 1, 5-FU (F) 750 mg/m 2 /day days 1-5] followed by radiotherapy (69.6 Gy) without (A) or with (B) standard dose cetuximab for 16 weeks throughout IC and radiotherapy (TPFE). Response to first IC-cycle (IC-1) with !30% endoscopically estimated tumor surface shrinkage (ETSS) was used to define early responders; early salvage TL was recommended to non-responders. The primary objective was 24 months LFS above 35% in arm B.

No abstract